キニジン硫酸塩の世界市場2022年-2026年

Technavioが発行した調査報告書(IRTNTR73837-22)
◆英語タイトル:Global Quinidine Sulfate Market 2022-2026
◆商品コード:IRTNTR73837-22
◆発行会社(リサーチ会社):Technavio
◆発行日:2022年8月20日
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、 ヨーロッパ、 アジア、 その他地域
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥350,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥560,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

Technavio社発行の最新調査レポートでは、世界のキニジン硫酸塩市場規模が2022年から2026年まで年平均6.7%成長し、427.29百万ドルに達すると予測しています。当書では、キニジン硫酸塩の世界市場を総合的に調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、疾患別(マラリア、不整脈)分析、顧客状況、地域別状況(北米、ヨーロッパ、アジア、アメリカ、ドイツ、中国、イギリス、カナダ)、推進要因・課題・動向、企業状況、企業分析などの項目をまとめています。なお、当書に掲載されている企業情報には、Bennet Pharmaceuticals Ltd.、Buchler GmbH、Cipla Ltd.、Ipca Laboratories Ltd.、Lark Laboratories India Ltd.、Merck and Co. Inc.、Merck KGaA、PRISM INDUSTRIES LTD.、Teva Pharmaceutical Industries Ltd.、VIVAN Life Sciences Pvt. Ltd.などが含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界のキニジン硫酸塩市場規模:疾患別
- マラリア治療用キニジン硫酸塩の市場規模2021-2026
- 不整脈治療用キニジン硫酸塩の市場規模2021-2026
・顧客状況
・地域別状況
- 北米のキニジン硫酸塩市場規模2021-2026
- ヨーロッパのキニジン硫酸塩市場規模2021-2026
- アジアのキニジン硫酸塩市場規模2021-2026
- アメリカのキニジン硫酸塩市場規模2021-2026
- ドイツのキニジン硫酸塩市場規模2021-2026
- 中国のキニジン硫酸塩市場規模2021-2026
- イギリスのキニジン硫酸塩市場規模2021-2026
- カナダのキニジン硫酸塩市場規模2021-2026
・推進要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することにより、また複数のソースからのデータを調査、統合、および合計することにより、市場の詳細な全体像を提示します。主要産業のインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。 Technavio社の市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選択方法と分析を提供します。
❖ レポートの概要 ❖

Global Quinidine Sulfate Market 2022-2026

Technavio has been monitoring the quinidine sulfate market and it is poised to grow by $ 427.29 mn during 2022-2026, accelerating at a CAGR of 6.7% during the forecast period. Our report on the quinidine sulfate market provides a holistic analysis, market size and forecast, trends, growth drivers, challenges, and vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing incidence of malaria, robust pipeline and drug approvals, and increasing mergers and acquisitions.

The quinidine sulfate market analysis includes type segment and geographic landscape.
Technavio’s quinidine sulfate market is segmented as below:

By Type
• Malaria
• Arrhythmias

By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the strong funding for the eradication of malaria as one of the prime reasons driving the quinidine sulfate market growth during the next few years. Also, an increase in the incidence of arrhythmia and increasing awareness among people about quinidine sulfate supplements will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the quinidine sulfate market covers the following areas:
• Quinidine sulfate market sizing
• Quinidine sulfate market forecast
• Quinidine sulfate market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading quinidine sulfate market vendors that include Bennet Pharmaceuticals Ltd., Buchler GmbH, Cipla Ltd., Ipca Laboratories Ltd., Lark Laboratories India Ltd., Merck and Co. Inc., Merck KGaA, PRISM INDUSTRIES LTD., Teva Pharmaceutical Industries Ltd., VIVAN Life Sciences Pvt. Ltd., Biophore India Pharmaceuticals Pvt. Ltd., Inga Laboratories P. Ltd., Koninklijke DSM NV, PMC Group Inc., PT Bio Farma, PT Sinkona Indonesia lestar, and Vital Laboratories Pvt. Ltd. Also, the quinidine sulfate market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Disease Type
o Exhibit 06: Executive Summary – Chart on Incremental Growth
o Exhibit 07: Executive Summary – Data Table on Incremental Growth
o Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis – Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
• 5 Market Segmentation by Disease Type
o 5.1 Market segments
o Exhibit 24: Chart on Disease Type – Market share 2021-2026 (%)
o Exhibit 25: Data Table on Disease Type – Market share 2021-2026 (%)
o 5.2 Comparison by Disease Type
o Exhibit 26: Chart on Comparison by Disease Type
o Exhibit 27: Data Table on Comparison by Disease Type
o 5.3 Malaria – Market size and forecast 2021-2026
o Exhibit 28: Chart on Malaria – Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Malaria – Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Malaria – Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Malaria – Year-over-year growth 2021-2026 (%)
o 5.4 Arrhythmias – Market size and forecast 2021-2026
o Exhibit 32: Chart on Arrhythmias – Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Arrhythmias – Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Arrhythmias – Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Arrhythmias – Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Disease Type
o Exhibit 36: Market opportunity by Disease Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America – Market size and forecast 2021-2026
o Exhibit 42: Chart on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America – Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America – Year-over-year growth 2021-2026 (%)
o 7.4 Europe – Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe – Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe – Year-over-year growth 2021-2026 (%)
o 7.5 Asia – Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia – Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia – Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o 7.7 US – Market size and forecast 2021-2026
o Exhibit 58: Chart on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US – Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US – Year-over-year growth 2021-2026 (%)
o 7.8 Germany – Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Germany – Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany – Year-over-year growth 2021-2026 (%)
o 7.9 China – Market size and forecast 2021-2026
o Exhibit 66: Chart on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on China – Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on China – Year-over-year growth 2021-2026 (%)
o 7.10 UK – Market size and forecast 2021-2026
o Exhibit 70: Chart on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on UK – Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on UK – Year-over-year growth 2021-2026 (%)
o 7.11 Canada – Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada – Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada – Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Bennet Pharmaceuticals Ltd.
o Exhibit 85: Bennet Pharmaceuticals Ltd. – Overview
o Exhibit 86: Bennet Pharmaceuticals Ltd. – Product / Service
o Exhibit 87: Bennet Pharmaceuticals Ltd. – Key offerings
o 10.4 Buchler GmbH
o Exhibit 88: Buchler GmbH – Overview
o Exhibit 89: Buchler GmbH – Product / Service
o Exhibit 90: Buchler GmbH – Key offerings
o 10.5 Cipla Ltd.
o Exhibit 91: Cipla Ltd. – Overview
o Exhibit 92: Cipla Ltd. – Business segments
o Exhibit 93: Cipla Ltd. – Key news
o Exhibit 94: Cipla Ltd. – Key offerings
o Exhibit 95: Cipla Ltd. – Segment focus
o 10.6 Ipca Laboratories Ltd.
o Exhibit 96: Ipca Laboratories Ltd. – Overview
o Exhibit 97: Ipca Laboratories Ltd. – Product / Service
o Exhibit 98: Ipca Laboratories Ltd. – Key offerings
o 10.7 Lark Laboratories India Ltd.
o Exhibit 99: Lark Laboratories India Ltd. – Overview
o Exhibit 100: Lark Laboratories India Ltd. – Product / Service
o Exhibit 101: Lark Laboratories India Ltd. – Key offerings
o 10.8 Merck and Co. Inc.
o Exhibit 102: Merck and Co. Inc. – Overview
o Exhibit 103: Merck and Co. Inc. – Business segments
o Exhibit 104: Merck and Co. Inc. – Key news
o Exhibit 105: Merck and Co. Inc. – Key offerings
o Exhibit 106: Merck and Co. Inc. – Segment focus
o 10.9 Merck KGaA
o Exhibit 107: Merck KGaA – Overview
o Exhibit 108: Merck KGaA – Business segments
o Exhibit 109: Merck KGaA – Key news
o Exhibit 110: Merck KGaA – Key offerings
o Exhibit 111: Merck KGaA – Segment focus
o 10.10 PRISM INDUSTRIES LTD.
o Exhibit 112: PRISM INDUSTRIES LTD. – Overview
o Exhibit 113: PRISM INDUSTRIES LTD. – Product / Service
o Exhibit 114: PRISM INDUSTRIES LTD. – Key offerings
o 10.11 Teva Pharmaceutical Industries Ltd.
o Exhibit 115: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 116: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 117: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 118: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 119: Teva Pharmaceutical Industries Ltd. – Segment focus
o 10.12 VIVAN Life Sciences Pvt. Ltd.
o Exhibit 120: VIVAN Life Sciences Pvt. Ltd. – Overview
o Exhibit 121: VIVAN Life Sciences Pvt. Ltd. – Product / Service
o Exhibit 122: VIVAN Life Sciences Pvt. Ltd. – Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 123: Inclusions checklist
o Exhibit 124: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 125: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 126: Research methodology
o Exhibit 127: Validation techniques employed for market sizing
o Exhibit 128: Information sources
o 11.5 List of abbreviations
o Exhibit 129: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Disease Type
Exhibits6: Executive Summary – Chart on Incremental Growth
Exhibits7: Executive Summary – Data Table on Incremental Growth
Exhibits8: Executive Summary – Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global – Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis – Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants – Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes – Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry – Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition – Five forces 2021 and 2026
Exhibits24: Chart on Disease Type – Market share 2021-2026 (%)
Exhibits25: Data Table on Disease Type – Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Disease Type
Exhibits27: Data Table on Comparison by Disease Type
Exhibits28: Chart on Malaria – Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Malaria – Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Malaria – Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Malaria – Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Arrhythmias – Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Arrhythmias – Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Arrhythmias – Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Arrhythmias – Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Disease Type ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America – Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America – Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America – Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America – Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe – Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe – Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia – Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia – Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US – Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US – Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US – Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US – Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany – Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany – Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on China – Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on China – Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on China – Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on China – Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK – Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK – Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK – Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK – Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada – Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada – Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Bennet Pharmaceuticals Ltd. – Overview
Exhibits86: Bennet Pharmaceuticals Ltd. – Product / Service
Exhibits87: Bennet Pharmaceuticals Ltd. – Key offerings
Exhibits88: Buchler GmbH – Overview
Exhibits89: Buchler GmbH – Product / Service
Exhibits90: Buchler GmbH – Key offerings
Exhibits91: Cipla Ltd. – Overview
Exhibits92: Cipla Ltd. – Business segments
Exhibits93: Cipla Ltd. – Key news
Exhibits94: Cipla Ltd. – Key offerings
Exhibits95: Cipla Ltd. – Segment focus
Exhibits96: Ipca Laboratories Ltd. – Overview
Exhibits97: Ipca Laboratories Ltd. – Product / Service
Exhibits98: Ipca Laboratories Ltd. – Key offerings
Exhibits99: Lark Laboratories India Ltd. – Overview
Exhibits100: Lark Laboratories India Ltd. – Product / Service
Exhibits101: Lark Laboratories India Ltd. – Key offerings
Exhibits102: Merck and Co. Inc. – Overview
Exhibits103: Merck and Co. Inc. – Business segments
Exhibits104: Merck and Co. Inc. – Key news
Exhibits105: Merck and Co. Inc. – Key offerings
Exhibits106: Merck and Co. Inc. – Segment focus
Exhibits107: Merck KGaA – Overview
Exhibits108: Merck KGaA – Business segments
Exhibits109: Merck KGaA – Key news
Exhibits110: Merck KGaA – Key offerings
Exhibits111: Merck KGaA – Segment focus
Exhibits112: PRISM INDUSTRIES LTD. – Overview
Exhibits113: PRISM INDUSTRIES LTD. – Product / Service
Exhibits114: PRISM INDUSTRIES LTD. – Key offerings
Exhibits115: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits116: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits117: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits118: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits119: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits120: VIVAN Life Sciences Pvt. Ltd. – Overview
Exhibits121: VIVAN Life Sciences Pvt. Ltd. – Product / Service
Exhibits122: VIVAN Life Sciences Pvt. Ltd. – Key offerings
Exhibits123: Inclusions checklist
Exhibits124: Exclusions checklist
Exhibits125: Currency conversion rates for US$
Exhibits126: Research methodology
Exhibits127: Validation techniques employed for market sizing
Exhibits128: Information sources
Exhibits129: List of abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ キニジン硫酸塩の世界市場2022年-2026年(Global Quinidine Sulfate Market 2022-2026)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆